TY - JOUR
T1 - Phenotypic spectrum of seizure disorders in MBD5-associated neurodevelopmental disorder
AU - Myers, Kenneth A.
AU - Marini, Carla
AU - Carvill, Gemma L.
AU - McTague, Amy
AU - Panetta, Julie
AU - Stutterd, Chloe
AU - Stanley, Thorsten
AU - Marin, Samantha
AU - Nguyen, John
AU - Barba, Carmen
AU - Rosati, Anna
AU - Scott, Richard H.
AU - Mefford, Heather C.
AU - Guerrini, Renzo
AU - Scheffer, Ingrid E.
N1 - Funding Information:
The Article Processing Charge was funded by the authors.
Funding Information:
K.A. Myers has received a travel grant from Zynerba and receives/has received research support from Fonds de
Publisher Copyright:
Copyright © 2021 The Author(s).
PY - 2021/4
Y1 - 2021/4
N2 - Objective To describe the phenotypic spectrum in patients with MBD5-associated neurodevelopmental disorder (MAND) and seizures; features of MAND include intellectual disability, epilepsy, psychiatric features of aggression and hyperactivity, and dysmorphic features including short stature and microcephaly, sleep disturbance, and ataxia. Methods We performed phenotyping on patients with MBD5 deletions, duplications, or point mutations and a history of seizures. Results Twenty-three patients with MAND and seizures were included. Median seizure onset age was 2.9 years (range 3 days–13 years). The most common seizure type was generalized tonic-clonic; focal, atypical absence, tonic, drop attacks, and myoclonic seizures occurred frequently. Seven children had convulsive status epilepticus and 3 nonconvulsive status epilepticus. Fever, viral illnesses, and hot weather provoked seizures. EEG studies in 17/21 patients were abnormal, typically showing slow generalized spike-wave and background slowing. Nine had drug-resistant epilepsy, although 3 eventually became seizure-free. All but one had moderate-to-severe developmental impairment. Epilepsy syndromes included Lennox-Gastaut syndrome, myoclonic-atonic epilepsy, and infantile spasms syndrome. Behavioral problems in 20/23 included aggression, self-injurious behavior, and sleep disturbance. Conclusions MBD5 disruption may be associated with severe early childhood-onset developmental and epileptic encephalopathy. Because neuropsychiatric dysfunction is common and severe, it should be an important focus of clinical management.
AB - Objective To describe the phenotypic spectrum in patients with MBD5-associated neurodevelopmental disorder (MAND) and seizures; features of MAND include intellectual disability, epilepsy, psychiatric features of aggression and hyperactivity, and dysmorphic features including short stature and microcephaly, sleep disturbance, and ataxia. Methods We performed phenotyping on patients with MBD5 deletions, duplications, or point mutations and a history of seizures. Results Twenty-three patients with MAND and seizures were included. Median seizure onset age was 2.9 years (range 3 days–13 years). The most common seizure type was generalized tonic-clonic; focal, atypical absence, tonic, drop attacks, and myoclonic seizures occurred frequently. Seven children had convulsive status epilepticus and 3 nonconvulsive status epilepticus. Fever, viral illnesses, and hot weather provoked seizures. EEG studies in 17/21 patients were abnormal, typically showing slow generalized spike-wave and background slowing. Nine had drug-resistant epilepsy, although 3 eventually became seizure-free. All but one had moderate-to-severe developmental impairment. Epilepsy syndromes included Lennox-Gastaut syndrome, myoclonic-atonic epilepsy, and infantile spasms syndrome. Behavioral problems in 20/23 included aggression, self-injurious behavior, and sleep disturbance. Conclusions MBD5 disruption may be associated with severe early childhood-onset developmental and epileptic encephalopathy. Because neuropsychiatric dysfunction is common and severe, it should be an important focus of clinical management.
UR - http://www.scopus.com/inward/record.url?scp=85108075851&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108075851&partnerID=8YFLogxK
U2 - 10.1212/NXG.0000000000000579
DO - 10.1212/NXG.0000000000000579
M3 - Article
C2 - 33912662
AN - SCOPUS:85108075851
SN - 2376-7839
VL - 7
JO - Neurology: Genetics
JF - Neurology: Genetics
IS - 2
M1 - e579
ER -